Arca Biopharma sell StockNews.com
Start price
20.11.23
/
50%
€1.65
Target price
20.11.24
-
Performance (%)
196.22%
Price
30.08.24
€2.22
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Arca Biopharma is trending in the completely wrong direction and now has a performance of 196.22%. Dividends of €2.85 are taken into consideration when calculating the performance. This prediction currently runs until 20.11.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | - | - |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat